Reducing Adhesions in Hernia Repair Meshes Through a Polysaccharide Coating

通过多糖涂层减少疝气修复网的粘连

基本信息

  • 批准号:
    9215133
  • 负责人:
  • 金额:
    $ 29.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-02-01 至 2020-01-31
  • 项目状态:
    已结题

项目摘要

Abstract Summary While all implants have capacity for generation of post-surgical adhesions, there is an estimated incidence rate as high a 58%, of adhesions which are so prohibitive that further intervention is warranted. Classical approaches of using polymer meshes or mesh coatings have not been universally adopted due to high cost, poor mesh mechanics, or capacity for immune activation and further amplification of chronic inflammation. Anti-adhesive surfaces such as the endothelial glycocalyx are formed by cell surface oligo- and polysaccharides, which are simple to reproduce and non-immunogenic. Therefore, we propose to create a family of polysaccharide-based polymers to coat hernia repair meshes mimicking the anti- adhesive properties of the glycocalyx. Preliminary data both in vitro and in rodent and pig models have shown this strategy to reduce adhesions beyond that of uncoated meshes. Our long-term goal is to develop a low-cost, biocompatible device coating which can prevent or reduce post-surgical adhesions. The objective of this proposal is to assess the range of polysaccharide chemistries capable of preventing adhesions, while retaining mesh repair durability and biocompatibility. The central hypothesis is that polysaccharide-based polymers, due to their capacity to form a water shell will resist protein adsorption and cell adhesion, reducing the number of post-surgical adhesions. This work will be accomplished in three aims: 1) Validate the capacity to prevent protein and cell adhesion on hernia meshes. 2) Evaluate impact of coating on post-surgical adhesion and durability of hernia repair. 3) Examine biocompatibility of polymer coatings in our rodent model. Our proposed work is innovative; it mimics simple saccharide chemistries to reduce adhesions; and by using naturally-derived molecules has a higher likelihood of biocompatibility. The expected outcomes include a platform technology, broadly applicable for use in reducing post-surgical adhesions. These results will positively impact the field of general surgery by providing a solution to a vexing problem that has complicated surgical care since meshes were introduced nearly 50 years ago. Future work will further assess biocompatibility at a molecular level, and translate to a large animal model of hernia repair and post-surgical adhesion.
摘要总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Horst A. von Recum其他文献

Sustained Release of Antifibrotic Nintedanib from Polymer Microparticles Reduces Dosing Frequency While Reducing Inflammation in Murine Idiopathic Pulmonary Fibrosis
  • DOI:
    10.1007/s10439-025-03729-8
  • 发表时间:
    2025-04-10
  • 期刊:
  • 影响因子:
    5.400
  • 作者:
    Emmanuel Einyat Opolot;Filip Goshevski;Rahul Chaudhary;Jessica A. Kilgore;Noelle S. Williams;Horst A. von Recum;Amar B. Desai
  • 通讯作者:
    Amar B. Desai
172. Spatially-Controlled Delivery of Cyclodextrin-Based Polyplexes from Solid Surfaces
  • DOI:
    10.1016/j.ymthe.2006.08.196
  • 发表时间:
    2006-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    In-Kyu Park;Horst A. von Recum;Shaoyi Jiang;Suzie H. Pun
  • 通讯作者:
    Suzie H. Pun
Bacteria invade the brain following intracortical microelectrode implantation, inducing gut-brain axis disruption and contributing to reduced microelectrode performance
细菌在皮层内微电极植入后侵入大脑,引发肠脑轴破坏,并导致微电极性能降低
  • DOI:
    10.1038/s41467-025-56979-4
  • 发表时间:
    2025-02-20
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    George F. Hoeferlin;Sarah E. Grabinski;Lindsey N. Druschel;Jonathan L. Duncan;Grace Burkhart;Gwendolyn R. Weagraff;Alice H. Lee;Christopher Hong;Meera Bambroo;Hannah Olivares;Tejas Bajwa;Jennifer Coleman;Longshun Li;William Memberg;Jennifer Sweet;Hoda Amani Hamedani;Abhinav P. Acharya;Ana G. Hernandez-Reynoso;Curtis Donskey;George Jaskiw;E. Ricky Chan;Andrew J. Shoffstall;A. Bolu Ajiboye;Horst A. von Recum;Liangliang Zhang;Jeffrey R. Capadona
  • 通讯作者:
    Jeffrey R. Capadona

Horst A. von Recum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Horst A. von Recum', 18)}}的其他基金

Sirolimus Delivery from Esophageal Stents to Prevent Scarring after Mucosectomy
从食管支架输送西罗莫司以防止粘膜切除术后留下疤痕
  • 批准号:
    9232682
  • 财政年份:
    2017
  • 资助金额:
    $ 29.07万
  • 项目类别:
In Vivo Assessment of Embryonic Stem Cell Teratoma Prevention
胚胎干细胞畸胎瘤预防的体内评估
  • 批准号:
    7804019
  • 财政年份:
    2010
  • 资助金额:
    $ 29.07万
  • 项目类别:
DNA Delivery for Treatment of Proliferative Vitreoretinopathy and Ocular Scarring
DNA 递送治疗增殖性玻璃体视网膜病变和眼部疤痕
  • 批准号:
    7761662
  • 财政年份:
    2009
  • 资助金额:
    $ 29.07万
  • 项目类别:
DNA Delivery for Treatment of Proliferative Vitreoretinopathy and Ocular Scarring
DNA 递送治疗增殖性玻璃体视网膜病变和眼部疤痕
  • 批准号:
    7573652
  • 财政年份:
    2009
  • 资助金额:
    $ 29.07万
  • 项目类别:
GENE THERAPY FOR TREATMENT OF RETINAL DEGENERATION
治疗视网膜变性的基因疗法
  • 批准号:
    6342594
  • 财政年份:
    2000
  • 资助金额:
    $ 29.07万
  • 项目类别:
GENE THERAPY FOR TREATMENT OF RETINAL DEGENERATION
治疗视网膜变性的基因疗法
  • 批准号:
    2710079
  • 财政年份:
    1999
  • 资助金额:
    $ 29.07万
  • 项目类别:
GENE THERAPY FOR TREATMENT OF RETINAL DEGENERATION
治疗视网膜变性的基因疗法
  • 批准号:
    6138143
  • 财政年份:
    1999
  • 资助金额:
    $ 29.07万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.07万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了